Efficacy and safety of low-power lasers for oral mucositis
Phase 2
- Conditions
- Hematopoietic malignancies requiring allogeneic/autologous hematopoietic stem cell transplantation
- Registration Number
- JPRN-jRCTs062220069
- Lead Sponsor
- ishi Hiromi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
(i) 18 years and older
(ii) Patients with hematopoietic malignancies who are scheduled for hematopoietic stem cell transplantation (not limited to first-line treatment)
(iii) No oral mucositis during the previous observation period
(iv) The patient must consent to the study
Exclusion Criteria
(i) Patients who have developed oral mucositis due to caries, dentures, or other irritations
(ii) Patients with a history of radiation therapy to the oral cavity
(iii) Other subjects deemed inappropriate by the principal investigator or subinvestigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method